A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ

被引：0
|
作者：
María Sol Brassesco
Gabriela Molinari Roberto
Lara Elis Delsin
Gabriel Carlos Baldissera
Mariana Medeiros
Kazuo Umezawa
Luiz Gonzaga Tone
机构：
[1] University of São Paulo,Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto
[2] University of São Paulo,Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School
[3] University of São Paulo,Department of Cell Biology, Ribeirão Preto Medical School
[4] Aichi Medical University School of Medicine,Department of Molecular Target Medicine
[5] University of São Paulo,Department of Pediatrics, Ribeirão Preto Medical School
来源：
Child's Nervous System | 2023年 / 39卷
关键词：
Children; Glioblastoma; NF-kB; DHMEQ; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1519 / 1528
页数：9
相关论文
共 50 条
  • [1] A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ
    Brassesco, Maria Sol
    Roberto, Gabriela Molinari
    Delsin, Lara Elis
    Baldissera, Gabriel Carlos
    Medeiros, Mariana
    Umezawa, Kazuo
    Tone, Luiz Gonzaga
    CHILDS NERVOUS SYSTEM, 2023, 39 (06) : 1519 - 1528
  • [2] Enhancement of radiosensitivity by the novel NF-kB inhibitor dhmeq in prostate cancer
    Kozakai, N
    Kikuchi, E
    Miyajima, A
    Horiguchi, Y
    Nakashima, J
    Umezawa, K
    Murai, M
    JOURNAL OF UROLOGY, 2006, 175 (04): : 91 - 92
  • [3] The NF-KB pathway and endocrine therapy resistance in breast cancer
    Khongthong, Phungern
    Roseweir, Antonia K.
    Edwards, Joanne
    ENDOCRINE-RELATED CANCER, 2019, 26 (06) : R369 - R380
  • [4] A novel NF-kB inhibitor, DHMEQ, induces apoptosis of ATL cells.
    Watanabe, T
    Horie, R
    Watanabe, M
    Ohsugi, T
    Ishida, T
    Yamaguchi, K
    Higashihara, M
    Umezawa, K
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 : S12 - S12
  • [5] Hypercapnic Acidosis And The Nf-Kb Pathway - Effects On P65 Subunit Of Nf-Kb
    Masterson, C. H.
    O'Toole, D. P.
    Laffey, J. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [6] Discovery of a novel anti-tumor agent targeting NF-kB pathway
    Ochi, H.
    Yanagi, T.
    Nakajo, M.
    Takemiya, A.
    Mochizuki, M.
    Oshima, H.
    Watanabe, W.
    Mishina, T.
    Nakamura, H.
    EJC SUPPLEMENTS, 2006, 4 (12): : 176 - 176
  • [7] A selective NF-kB inhibitor, DHMEQ, inhibits allergic inflammation in a murine model of asthma
    Shimizu, K.
    Satoshi, K.
    Ozaki, M.
    Todo, S.
    Umezawa, K.
    Nishimura, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [8] A Selective NF-kB Inhibitor, DHMEQ, Inhibits Allergic Inflammation in a Murine Model of Asthma
    Shimizu, K.
    Konno, S.
    Todo, S.
    Umezawa, K.
    Nishimura, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [9] Mir-194-3p suppresses tumorigenic potential of glioblastoma stem cells by targeting the canonical NF-kB pathway
    Singh, Rajbir
    Palanichamy, Kamalakannan
    Jacob, John R.
    Chakravarti, Arnab
    CANCER RESEARCH, 2016, 76
  • [10] Dual roles of NF-kB in cell survival and implications of NF-kB inhibitors in neuroprotective therapy
    Zheng-hong QIN~(2
    ActaPharmacologicaSinica, 2007, (12) : 1859 - 1872
12345